Mochida S, Nakao M, Nakayama N, et al. Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies. J Gastroenterol. 2016;51:999–1010.

Article  CAS  PubMed  Google Scholar 

Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology. Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update. Hepatol Res. 2020;50:892–923.

Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.

Article  PubMed  Google Scholar 

Kamitsukasa H, Iri M, Tanaka A, et al. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol. 2015;87:589–600.

Article  CAS  PubMed  Google Scholar 

Obara N, Inoue J, Endo H, et al. Spontaneous reactivation of hepatitis B virus with S gene mutations in an elderly patient with diabetic nephropathy. Clin J Gastroenterol. 2020;13(5):914–9.

Article  PubMed  Google Scholar 

Takakusagi S, Takagi H, Yokoyama Y, et al. Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases. Clin J Gastroenterol. 2021;14(4):1202–10.

Article  PubMed  Google Scholar 

Sasaki T, Kakisaka K, Miyasaka A, et al. Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection. Clin J Gastroenterol. 2024;17(4):683–90.

Article  PubMed  Google Scholar 

Mochida S, Takikawa Y, Nakayama N, et al. Diagnostic criteria of acute liver failure: a report by the intractable hepato-biliary diseases study group of Japan. Hepatol Res. 2011;41:805–12.

Article  PubMed  Google Scholar 

Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47:849–61.

Article  PubMed  PubMed Central  Google Scholar 

Uchida Y, Kouyama JI, Naiki K, et al. Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient. Hepatol Res. 2014;44(11):1130–41.

Article  CAS  PubMed  Google Scholar 

Inoue T, Tanaka Y. Cross-protection of hepatitis B vaccination among different genotypes. Vaccines (Basel). 2020;8(3):456.

Article  CAS  PubMed  Google Scholar 

Kremsdorf D, Lekbaby B, Bablon P, et al. Alternative splicing of viral transcripts: the dark side of HBV. Gut. 2021;70(12):2373–82.

Article  CAS  PubMed  Google Scholar 

Paul S, Dickstein A, Saxena A, et al. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis. Hepatology. 2017;66(2):379–88.

Article  CAS  PubMed  Google Scholar 

Fukuda W, Hanyu T, Katayama M, et al. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan. Ann Rheum Dis. 2017;76(6):1051–6.

Article  CAS  PubMed  Google Scholar 

Yang HC, Tsou HH, Pei SN, et al. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection. J Hepatol. 2018;69(2):286–92.

Article  CAS  PubMed  Google Scholar 

Mochida S, Nakayama N, Terai S, et al. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res. 2022;52:417–21.

Article  CAS  PubMed  Google Scholar 

Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325–9.

Article  CAS  PubMed  Google Scholar 

Ueda Y, Marusawa H, Egawa H, et al. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation. Antivir Ther. 2011;16:479–87.

Article  CAS  PubMed  Google Scholar 

Ito K, Qin Y, Guarnieri M, et al. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol. 2010;84:12850–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salpini R, Colagrossi L, Bellocchi MC, et al. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology. 2015;61:823–33.

Article  CAS  PubMed  Google Scholar 

Sakamoto K, Umemura T, Ito K, et al. Virological factors associated with the occurrence of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection analyzed through ultradeep sequencing. J Infect Dis. 2020;14(221):400–7.

Google Scholar 

Arasawa S, Takeda H, Takai A, et al. Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatol Commun. 2023;7: e0047.

Article  PubMed  PubMed Central  Google Scholar 

Soussan P, Garreau F, Zylberberg H, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest. 2000;105:55–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soussan P, Tuveri R, Nalpas B, et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol. 2003;38:343–8.

Article  CAS  PubMed  Google Scholar 

Mancini-Bourgine M, Bayard F, Soussan P, et al. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. J Virol. 2007;81:4963–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu YW, Ren YD, Bai J, et al. The spliced variant of hepatitis B virus protein, HBSP, interacts with Bcl-2/Bcl-xL in vitro and induces apoptosis in HepG2 cells. IUBMB Life. 2008;60:700–2.

Article  CAS  PubMed  Google Scholar 

Lu YW, Tan TL, Chan V, et al. The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells. Biochem Biophys Res Commun. 2006;351:64–70.

Article  CAS  PubMed  Google Scholar 

Chen J-Y, Chen W-N, Liu L-L, et al. Hepatitis B spliced protein (HBSP) generated by a spliced hepatitis B virus RNA participates in abnormality of fibrin formation and functions by binding to fibrinogen γ chain. J Med Virol. 2010;82:2019–26.

Article  CAS  PubMed  Google Scholar 

Chen J-Y, Chen W-N, Jiao B-Y, et al. Hepatitis B spliced protein (HBSP) promotes the carcinogenic effects of benzo [alpha] pyrene by interacting with microsomal epoxide hydrolase and enhancing its hydrolysis activity. BMC Cancer. 2014;14:282.

Article  PubMed  PubMed Central  Google Scholar 

Rosmorduc O, Petit MA, Pol S, et al. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology. 1995;22:10–9.

CAS  PubMed  Google Scholar 

Rosmorduc O, Sirma H, Soussan P, et al. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J Gen Virol. 1999;80:1253–62.

Article  CAS  PubMed  Google Scholar 

Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41(5):591–5.

Article  CAS  PubMed  Google Scholar 

Nishida N, Sawai H, Matsuura K, et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE. 2012;7(6): e39175.